SAP announced the general availability of SAP Information Collaboration Hub for Life Sciences, option for U.S. supply chain, a blockchain-technology hub to help eliminate counterfeit products along the pharmaceutical supply chain.
The hub is designed to authenticate pharmaceutical packaging returned from hospitals and pharmacies to wholesalers before products are resold. U.S. wholesalers encounter nearly 60 million returns annually, accounting for an estimated US$7 billion.
The blockchain-based solution helps customers comply with the U.S. Drug Supply Chain Security Act (DSCSA), which requires that as of November 2019 wholesalers verify prescription drugs that are returned and intended for resale. The mandate is intended to protect consumers from fake, contaminated and stolen medication.
The new software allows customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers’ data stored in the blockchain. The software was developed in co-innovation with AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.